| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |